Swedish Orphan Biovit Ord (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIOVF | GMAB | JAZZ | ||
| Company | Swedish Orphan Biovit Ord | Genmab A/S ADR | Jazz Pharma Plc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 48.2050 | 30.69 | 246.38 | ||
| High | 48.2050 | 31.61 | 251.92 | ||
| Low | 48.2050 | 30.69 | 244.35 | ||
| Last | 48.2050 | 31.42 | 248.95 | ||
| Change | -0.8232 | +0.57 | +0.97 | ||
| Percent Change | -1.68% | +1.85% | +0.39% | ||
| Volume | 1,500 | 3,516,900 | 553,500 | ||
| 20-Day Average Volume | 305 | 2,039,480 | 813,275 | ||
| Previous | 49.0282 | 30.85 | 247.98 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 37.4979 | 29.29 | 253.38 | ||
| 20-Day Raw Stochastic | 95.90% | 90.57% | 40.47% | ||
| 20-Day Relative Strength | 73.29 | 67.36 | 52.09 | ||
| Weighted Alpha | N/A | +31.22 | +98.11 | ||
| Today's Opinion | N/A | 56% Buy | 80% Buy | ||
| Yesterday's Opinion | N/A | 56% Buy | 80% Buy | ||
| Last Month's Opinion | N/A | 8% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.71% since 04/27/26 | +7.38% since 08/05/26 | -4.83% since 08/05/26 | ||
| Low | 47.3500 on 05/01/26 | 28.47 on 08/06/26 | 244.35 on 08/12/26 | ||
| High | 49.0282 on 07/09/26 | 31.79 on 08/07/26 | 264.03 on 08/06/26 | ||
| 1-Month | |||||
| %Chg | +0.43% since 06/04/26 | +8.34% since 07/10/26 | +2.10% since 07/10/26 | ||
| Low | 48.2050 on 07/28/26 | 27.86 on 07/20/26 | 233.46 on 07/15/26 | ||
| High | 49.0282 on 07/09/26 | 31.79 on 08/07/26 | 265.05 on 08/05/26 | ||
| 3-Month | |||||
| %Chg | +11.71% since 04/27/26 | +15.98% since 05/12/26 | +9.26% since 05/12/26 | ||
| Low | 47.3500 on 05/01/26 | 23.62 on 06/03/26 | 220.74 on 06/18/26 | ||
| High | 49.0282 on 07/09/26 | 31.79 on 08/07/26 | 265.05 on 08/05/26 | ||
| 6-Month | |||||
| %Chg | +30.28% since 01/14/26 | +6.18% since 02/12/26 | +49.71% since 02/12/26 | ||
| Low | 39.8701 on 03/31/26 | 23.62 on 06/03/26 | 165.36 on 02/17/26 | ||
| High | 49.0282 on 07/09/26 | 31.79 on 08/07/26 | 265.05 on 08/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 17,160,982 | 19,235,994 | 16,097,621 | ||
| Shares Outstanding, K | 356,000 | 623,533 | 64,915 | ||
| Annual Sales, $M | 2,885,920,000 | 3,720,000,000 | 4,267,590,000 | ||
| Annual Net Income, $M | 48,850,000 | 963,000,000 | -356,150,000 | ||
| Last Qtr Sales, $M | 837,320,000 | 1,155,000,000 | 1,208,300,000 | ||
| Last Qtr Income, $M | 117,130,000 | 303,000,000 | 192,800,000 | ||
| 60-Month Beta | 0.35 | 0.83 | 0.32 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.42 on 07/16/26 | 0.54 on 08/06/26 | 5.71 on 08/03/26 | ||
| Latest Earnings Date | 10/19/26 | 11/05/26 | 11/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 23.24 | 22.21 | 11.10 | ||